Eton Pharmaceuticals (ETON) EPS (Basic) (QoQ) (2018 - 2025)
Eton Pharmaceuticals (ETON) EPS (Basic) (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.36 Bn | 43.40 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.77 Bn | 40.12 Bn | 2.15 Bn |
| 3 | Zoetis | 32.39 Bn | 30.72 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.94 Bn | 18.06 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.63 Bn | 15.24 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.00 Bn | 11.47 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Eton Pharmaceuticals | 1.71 Bn | 1.68 Bn | 25.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 187.96% |
| Sep 30, 2025 | -74,445.45% |
| Jun 30, 2025 | 99.84% |
| Mar 31, 2025 | -153.18% |
| Dec 31, 2024 | -100.10% |
| Sep 30, 2024 | 120.52% |
| Jun 30, 2024 | -274.75% |
| Mar 31, 2024 | -43,209.92% |
| Dec 31, 2023 | -222.86% |
| Sep 30, 2023 | -112.64% |
| Jun 30, 2023 | 270.94% |
| Mar 31, 2023 | -193.39% |
| Dec 31, 2022 | 192.95% |
| Sep 30, 2022 | 99.81% |
| Jun 30, 2022 | -29,334.36% |
| Mar 31, 2022 | -611.09% |
| Dec 31, 2021 | 117.10% |
| Sep 30, 2021 | -201.51% |
| Jun 30, 2021 | -138.22% |
| Mar 31, 2021 | 157.18% |